AI Reads Routine Mammograms to Predict Breast Cancer HER2 Status Without Biopsy
A dual-center study shows that a deep learning radiomics model applied to routine mammograms can noninvasively predict HER2-positive and HER2-low ...
A dual-center study shows that a deep learning radiomics model applied to routine mammograms can noninvasively predict HER2-positive and HER2-low ...
A multicenter real-world study found that first-line trastuzumab deruxtecan doubled progression-free survival compared with chemotherapy in HER2-altered advanced NSCLC, while ...
A new review maps the engineering strategies, from dual-target receptors to tumor microenvironment remodeling, that could finally bring CAR-T cell ...
A Brazilian study found that an AI model's measure of HER2 staining heterogeneity within breast cancer samples predicts where pathologists ...
A comprehensive new review maps how NF-κB signalling drives breast cancer progression, subtype-specific therapy resistance and tumour-microenvironment crosstalk, and argues ...
UCLA oncologist Dr. Dennis Slamon has received the 2026 Albany Prize for discoveries that identified HER2-positive breast cancer and produced ...
A HER2-targeted mRNA lipid nanoparticle vaccine combined with fractionated radiotherapy suppressed tumor growth and reprogrammed the immune microenvironment in a ...
A Lithuanian case report describes a boy with novel compound heterozygous ERBB2 variants, only the second family ever documented with ...
A two-cohort study of 1,687 biliary tract cancer patients found that a prior breast cancer diagnosis was significantly more prevalent ...
A Vietnamese cohort study finds that the pleomorphic variant of invasive lobular carcinoma independently predicts axillary lymph node metastasis even ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine